1. 1) Miyazawa, T.; Suzuki, T.; Yasuda, K.; Fujimoto, K.; Meguro, K; Sasaki, H. Accumulation of phospholipid hydroperoxides in red blood cell membranes in Alzheimer disease. in Oxygen Radicals (Yagi, K.; Kondo, M.; Niki, E.; Yoshikawa, T.; Eds.), Elsevier Sci. Publ., Amsterdam, pp. 327-330 (1992).
2. 2) Kiko, T.; Nakagawa, K.; Tsuduki, T.; Suzuki, T.; Arai, H.; Miyazawa, T. Significance of lutein in red blood cells of Alzheimer’s disease patients. J. Alzheimers Dis. 28, 593-600 (2012).
3. 3) Goodall, H.B.; Reid, A.H.; Findlay, D.J.; Hind, C.; Kay, J.; Coghill, G. Irregular distortion of the erythrocytes (acanthocytes, spur cells) in senile dementia. Dis. Markers 12, 23-41 (1994).
4. 4) Bosman, G.J.; Bartholomeus, I.G.; de Man, A.J.; van Kalmthout, P.J.; de Grip, W.J. Erythrocyte membrane characteristics indicate abnormal cellular aging in patients with Alzheimer’s disease. Neurobiol. Aging 12, 13-18 (1991).
5. 5) Mohanty, J.D.; Eckley, D.M.; Williamson, J.D.; Launer, L.J.; Rifkind, J.M. Do red blood cell-beta-amyloid interactions alter oxygen delivery in Alzheimer’s disease? Adv. Exp. Med. Biol. 614, 29-35 (2008).